Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122600059> ?p ?o ?g. }
- W2122600059 endingPage "136" @default.
- W2122600059 startingPage "132" @default.
- W2122600059 abstract "Infections remain a major cause of morbidity and mortality in patients undergoing autologous or allogeneic hematopoietic stem cell transplantation (HSCT). About 80% of patients experience fever during aplasia and early engraftment despite oral antibacterial chemoprophylaxis.In a pilot study, 50 patients undergoing autologous or allogeneic HSCT received a prophylactic antibacterial treatment with intravenous piperacillin/tazobactam beginning on day of stem cell or bone marrow transfusion. They were analyzed retrospectively for frequencies of fever of unknown origin (FUO), documented infection, bacteremia and death because of infection. Furthermore, data from microbiological monitoring and tolerability were evaluated.Among 28 autologous transplanted patients, 10 (36%) developed fever more than 38.5 degrees C; 9/10 FUO, 1/28 pulmonary infiltrates. Eighteen patients (64%) remained without any symptom of infection. In the allogeneic group (n = 22), there were eight patients (36%) with FUO, and five patients (23%) with documented infections (pneumonia 2, enteritis 1, pyelonephritis 1, Escherichia coli bacteremia 1). In nine patients (41%), escalation of antimicrobial treatment was not necessary. The majority of detected microbes in cultures of throat and nose secretions, blood, urine and stool were gram-positive bacteria (77.8%), among them Staphylococcus epidermidis (23.5%), streptococci (group A, B, C; 21.0%) and enterococci (10.6%). Incidence of gram-negative bacteria and fungi was similar with 11.8% and 10.4%, respectively. The most frequent gram-negative strains were Escherichia coli (6.5%) and Pseudomonas aeruginosa (1.7%). There was no severe toxicity or hypersensitivity.Compared to oral decontamination and chemoprophylaxis, an intravenous prophylactic regimen as described above could be an effective and well-tolerated approach in prevention of bacterial infections and related complications, with a higher acceptance in recipients of bone marrow or stems cell grafts. Further evaluation in comparison with fluoroquinolone prophylaxis regarding efficacy, development of resistances as well as cost-benefit analyses is warranted." @default.
- W2122600059 created "2016-06-24" @default.
- W2122600059 creator A5017002895 @default.
- W2122600059 creator A5026849709 @default.
- W2122600059 creator A5043647870 @default.
- W2122600059 creator A5061229750 @default.
- W2122600059 creator A5071002686 @default.
- W2122600059 creator A5074209268 @default.
- W2122600059 creator A5083804346 @default.
- W2122600059 date "2002-09-01" @default.
- W2122600059 modified "2023-10-14" @default.
- W2122600059 title "Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation" @default.
- W2122600059 cites W138896090 @default.
- W2122600059 cites W1541287496 @default.
- W2122600059 cites W1859269909 @default.
- W2122600059 cites W1932294144 @default.
- W2122600059 cites W1984864482 @default.
- W2122600059 cites W2004312195 @default.
- W2122600059 cites W2009358917 @default.
- W2122600059 cites W2016366382 @default.
- W2122600059 cites W2019593819 @default.
- W2122600059 cites W2036373004 @default.
- W2122600059 cites W2087524450 @default.
- W2122600059 cites W2090950403 @default.
- W2122600059 cites W2091343161 @default.
- W2122600059 cites W2110901116 @default.
- W2122600059 cites W2140904509 @default.
- W2122600059 cites W2146917045 @default.
- W2122600059 cites W2161554984 @default.
- W2122600059 cites W2169482637 @default.
- W2122600059 cites W2176794539 @default.
- W2122600059 cites W2324826897 @default.
- W2122600059 doi "https://doi.org/10.1034/j.1399-3062.2002.t01-1-01014.x" @default.
- W2122600059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12421457" @default.
- W2122600059 hasPublicationYear "2002" @default.
- W2122600059 type Work @default.
- W2122600059 sameAs 2122600059 @default.
- W2122600059 citedByCount "13" @default.
- W2122600059 countsByYear W21226000592013 @default.
- W2122600059 countsByYear W21226000592014 @default.
- W2122600059 countsByYear W21226000592018 @default.
- W2122600059 countsByYear W21226000592020 @default.
- W2122600059 crossrefType "journal-article" @default.
- W2122600059 hasAuthorship W2122600059A5017002895 @default.
- W2122600059 hasAuthorship W2122600059A5026849709 @default.
- W2122600059 hasAuthorship W2122600059A5043647870 @default.
- W2122600059 hasAuthorship W2122600059A5061229750 @default.
- W2122600059 hasAuthorship W2122600059A5071002686 @default.
- W2122600059 hasAuthorship W2122600059A5074209268 @default.
- W2122600059 hasAuthorship W2122600059A5083804346 @default.
- W2122600059 hasConcept C126322002 @default.
- W2122600059 hasConcept C141071460 @default.
- W2122600059 hasConcept C197934379 @default.
- W2122600059 hasConcept C2777408962 @default.
- W2122600059 hasConcept C2777637488 @default.
- W2122600059 hasConcept C2778193466 @default.
- W2122600059 hasConcept C2778375690 @default.
- W2122600059 hasConcept C2779443120 @default.
- W2122600059 hasConcept C2911091166 @default.
- W2122600059 hasConcept C501593827 @default.
- W2122600059 hasConcept C523546767 @default.
- W2122600059 hasConcept C54355233 @default.
- W2122600059 hasConcept C71924100 @default.
- W2122600059 hasConcept C86803240 @default.
- W2122600059 hasConcept C89423630 @default.
- W2122600059 hasConcept C90924648 @default.
- W2122600059 hasConceptScore W2122600059C126322002 @default.
- W2122600059 hasConceptScore W2122600059C141071460 @default.
- W2122600059 hasConceptScore W2122600059C197934379 @default.
- W2122600059 hasConceptScore W2122600059C2777408962 @default.
- W2122600059 hasConceptScore W2122600059C2777637488 @default.
- W2122600059 hasConceptScore W2122600059C2778193466 @default.
- W2122600059 hasConceptScore W2122600059C2778375690 @default.
- W2122600059 hasConceptScore W2122600059C2779443120 @default.
- W2122600059 hasConceptScore W2122600059C2911091166 @default.
- W2122600059 hasConceptScore W2122600059C501593827 @default.
- W2122600059 hasConceptScore W2122600059C523546767 @default.
- W2122600059 hasConceptScore W2122600059C54355233 @default.
- W2122600059 hasConceptScore W2122600059C71924100 @default.
- W2122600059 hasConceptScore W2122600059C86803240 @default.
- W2122600059 hasConceptScore W2122600059C89423630 @default.
- W2122600059 hasConceptScore W2122600059C90924648 @default.
- W2122600059 hasIssue "3" @default.
- W2122600059 hasLocation W21226000591 @default.
- W2122600059 hasLocation W21226000592 @default.
- W2122600059 hasOpenAccess W2122600059 @default.
- W2122600059 hasPrimaryLocation W21226000591 @default.
- W2122600059 hasRelatedWork W1990197915 @default.
- W2122600059 hasRelatedWork W2051018641 @default.
- W2122600059 hasRelatedWork W2087016115 @default.
- W2122600059 hasRelatedWork W2305775430 @default.
- W2122600059 hasRelatedWork W2427186628 @default.
- W2122600059 hasRelatedWork W2465571689 @default.
- W2122600059 hasRelatedWork W3000123036 @default.
- W2122600059 hasRelatedWork W3191427281 @default.
- W2122600059 hasRelatedWork W4301072685 @default.
- W2122600059 hasRelatedWork W4311628015 @default.
- W2122600059 hasVolume "4" @default.